Loading...
19 May 2025 / Brief
Email
Linkedin
Facebook
X
Copy LinkThe US administration has issued several executive orders (EOs) related to the nation’s pharmaceutical supply creating a trifecta of challenges for drug companies regarding pricing, onshoring, and tariffs. The most recent EO on May 12 seeks to lower the price of prescription drugs in the US by implementing a “most favored nation” (MFN) pricing requirement.
The order directs the Secretary of Health and Human Services to communicate price targets to pharmaceutical manufacturers within 30 days to bring US drug prices in line with comparably developed nations.
Separately, there is another EO directing the industry to increase US manufacturing and an in-process US Department of Commerce investigation, which is expected to result in tariffs on pharmaceuticals. The confluence of these factors has been called a “worst-case scenario” for the global pharmaceutical industry.
Why it matters: Price increases and supply chain disruptions are increasingly likely
myTCB® Members get exclusive access to webcasts, publications, data and analysis, plus discounts to events.
November PCE: Are Consumers Spending Beyond Their Means?
January 22, 2026
Retail Sales Highlight Affordability Issues
January 14, 2026
No, Tamer CPI Does Not Mean Inflation Peaked
January 13, 2026
Exiting International Climate Pacts Will Leave The US Isolated
January 08, 2026
Robust Q3 GDP: Finding a Signal in the Noise
December 23, 2025
Fed Doves Get Nice Holiday Gift as CPI Inflation Drops
December 18, 2025
Charts
As a visual explainer of CED’s Solutions Brief, this infographic outlines CED's policy priorities for 2026.
LEARN MORE
Charts
The proliferation of easy-to-use generative AI requires that policymakers and business leaders each play an important role.
LEARN MORE
Charts
A hyperpolarized environment, diminished trust in our nation’s leaders.
LEARN MORE
PRESS RELEASE
CED Outlines 2026 Policy Priorities Ahead of Nation’s 250th Anniversary
January 20, 2026
IN THE NEWS
Denise Dahlhoff on How CEOs Are Talking About Tariffs—without Saying “Tarif…
May 21, 2025
IN THE NEWS
Erin McLaughlin on Tariff Policy
April 07, 2025
IN THE NEWS
Erin McLaughlin on Reshoring Factors
April 05, 2025
IN THE NEWS
Erin McLaughlin on US Reshoring
April 02, 2025
IN THE NEWS
Erin McLaughlin: How policy uncertainty may exacerbate infrastructure chall…
March 19, 2025
